KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT (2016 - 2026)

Medpace Holdings filings provide 12 years of EBT readings, the most recent being $147.6 million for Q1 2026.

  • On a quarterly basis, EBT rose 24.9% to $147.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $571.8 million, a 18.8% increase, with the full-year FY2025 number at $542.4 million, up 13.96% from a year prior.
  • EBT hit $147.6 million in Q1 2026 for Medpace Holdings, down from $156.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $156.8 million in Q4 2025 to a low of $62.0 million in Q2 2022.
  • Median EBT over the past 5 years was $110.5 million (2024), compared with a mean of $105.0 million.
  • Biggest five-year swings in EBT: skyrocketed 49.61% in 2022 and later increased 1.6% in 2023.
  • Medpace Holdings' EBT stood at $73.6 million in 2022, then grew by 23.17% to $90.7 million in 2023, then soared by 47.6% to $133.9 million in 2024, then rose by 17.14% to $156.8 million in 2025, then dropped by 5.89% to $147.6 million in 2026.
  • The last three reported values for EBT were $147.6 million (Q1 2026), $156.8 million (Q4 2025), and $142.8 million (Q3 2025) per Business Quant data.